PAYX
47
5
WBA
45
-2
MA
62
4
LB
64
2
ADP
69
3
ECL
45
-2
CSX
43
4
AES
57
3
YUM
58
-3
VZ
54
2
EQR
47
2
HP
28
-12
HRB
49
13
COP
50
3
STZ
47
2
HRL
45
3
MCHP
46
4
DLTR
43
3
PG
68
4
ADM
39
3
PAYX
47
5
WBA
45
-2
MA
62
4
LB
64
2
ADP
69
3
ECL
45
-2
CSX
43
4
AES
57
3
YUM
58
-3
VZ
54
2
EQR
47
2
HP
28
-12
HRB
49
13
COP
50
3
STZ
47
2
HRL
45
3
MCHP
46
4
DLTR
43
3
PG
68
4
ADM
39
3
Financhill
Back

Atara Biotherapeutics 10K Form

Sell
20

ATRA
Atara Biotherapeutics

Last Price:
$6.91
Seasonality Move:
-15.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATRA News And Ratings

See the #1 stock for the next 7 days that we like better than ATRA

ATRA Financial Statistics

Sales & Book Value

Annual Sales: $128.9M
Cash Flow: $-24.6M
Price / Cash Flow: 0
Annual Sales: $-16.60
Price / Book: 0

Profitability

EPS (TTM): -12.97000
Net Income (TTM): $-85.4M
Gross Margin: $107.9M
Return on Equity: -2818.48%
Return on Assets: -61.01%

Atara Biotherapeutics Earnings Forecast

Key Atara Biotherapeutics Financial Ratios

  • The Gross Profit Margin over the past 7 years for ATRA is 83.71%.
  • The Selling, General & Administrative Expenses for ATRA have been equal to 30.93% of Gross Profit Margin.
  • The Research & Development expenses have been 117.48% of Revenue.
  • The Net Earning history of ATRA is -66.23% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 5 years.

Atara Biotherapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ATRA
CUSIP: 046513
Website: atarabio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.48
Quick Ratio: 0.33

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATRA Technical Analysis vs Fundamental Analysis

Sell
20
Atara Biotherapeutics (ATRA) is a Sell

Is Atara Biotherapeutics a Buy or a Sell?